Determinants of Genetic Diversity of Spontaneous Drug Resistance in Bacteria. Issue 3 (1st July 2016)

• Record Type: Journal Article
• Authors: Couce, Alejandro; Rodríguez-Rojas, Alexandro; Blázquez, Jesús
• Is Part Of: Genetics. Volume 203:Issue 3(2016)
• Page Start: 1369
• Page End: 1380
• Publication Date: 2016-07-01
• Subjects: genetic diversity -- clonal heterogeneity -- antibiotic resistance cost -- population size -- mutation; Genetics -- Periodicals; 576.5
• DOI: 10.1534/genetics.115.185355
• Languages: English
• ISSNs: 0016-6731

Abstract

Abstract: Any pathogen population sufficiently large is expected to harbor spontaneous drug-resistant mutants, often responsible for disease relapse after antibiotic therapy. It is seldom appreciated, however, that while larger populations harbor more mutants, the abundance distribution of these mutants is expected to be markedly uneven. This is because a larger population size allows early mutants to expand for longer, exacerbating their predominance in the final mutant subpopulation. Here, we investigate the extent to which this reduction in evenness can constrain the genetic diversity of spontaneous drug resistance in bacteria. Combining theory and experiments, we show that even small variations in growth rate between resistant mutants and the wild type result in orders-of-magnitude differences in genetic diversity. Indeed, only a slight fitness advantage for the mutant is enough to keep diversity low and independent of population size. These results have important clinical implications. Genetic diversity at antibiotic resistance loci can determine a population's capacity to cope with future challenges ( i.e., second-line therapy). We thus revealed an unanticipated way in which the fitness effects of antibiotic resistance can affect the evolvability of pathogens surviving a drug-induced bottleneck. This insight will assist in the fight against multidrug-resistant microbes, as well as contribute to theories aimed at predicting cancer evolution.